Clinical Trials
The surgeons at Retina and Macula Specialists are regularly involved in multi-centre research trials. The outcomes of these trials benefit eye patients across the world.
Study WR42221 is a Phase IIIb, global, multicenter, randomized, visual assessor-masked study designed to assess the efficacy, safety, and pharmacokinetics of the Port Delivery System with ranibizumab (PDS) 100 mg/mL delivered every 36 weeks (Q36W) compared with every 24 weeks (Q24W) in patients with neovascular age-related macular degeneration (nAMD).
Principal Investigator
Professor Adrian Fung
Have a question? Call one of our clinics today.
© 2019-2024 Eye Specialists Centre | Privacy Policy | Disclaimer | Website design: